Ocular Therapeutix OCUL Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $666.7M+90.7% | $737.06M+88.0% | $344.77M-19.3% | $391.13M-14.9% | $349.68M-27.6% | ||
| $24.35M-3.5% | $30.65M-5.4% | $30.77M+1.8% | $30.41M+0.6% | $25.22M-5.0% | ||
| $3.74M+14.3% | $3.56M+17.2% | $3.49M+45.0% | $3.04M+19.3% | $3.27M+27.0% | ||
| $706M+82.1% | $782.13M+77.4% | $386.98M-18.2% | $433.38M-13.1% | $387.69M-25.4% | ||
| $18.43M+70.9% | $19.68M+110% | $16.95M+68.7% | $10.46M-3.9% | $10.78M-5.8% | ||
| $732.53M+80.5% | $808.06M+76.5% | $410.88M-16.2% | $451.33M-12.7% | $405.92M-24.7% | ||
| $8.03M+73.5% | $4.15M-0.5% | $6.26M+56.5% | $5.89M+59.6% | $4.63M-28.3% | ||
| $47.68M+25.7% | $50.81M+22.9% | $49.29M+35.6% | $42.93M+43.2% | $37.93M+56.1% | ||
| $72.06M+4.1% | $71.34M+4.1% | $70.62M+4.1% | $69.91M+4.1% | $69.2M+4.1% | ||
| $150.96M+7.8% | $153.75M+7.8% | $152.65M+10.3% | $145.42M+4.3% | $139.99M+6.9% | ||
| $22K+37.5% | $22K+37.5% | $18K+12.5% | $17K+6.3% | $16K+6.7% | ||
| -$1.25B-30.4% | -$1.16B-29.8% | -$1.09B-29.6% | -$1.02B-26.9% | -$955.14M-25.3% | ||
| $581.57M+119% | $654.31M+107% | $258.23M-26.6% | $305.92M-19.0% | $265.93M-34.8% | ||
| $732.53M+80.5% | $808.06M+76.5% | $410.88M-16.2% | $451.33M-12.7% | $405.92M-24.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Ocular Therapeutix's total assets?
- Ocular Therapeutix (OCUL) holds $732.5M in total assets, up 80.5% year over year.
- How much debt does Ocular Therapeutix have?
- Ocular Therapeutix carries $79.5M in total debt against $581.6M of shareholders' equity, a debt-to-equity ratio of 0.14.
- How much cash does Ocular Therapeutix have?
- Ocular Therapeutix holds $666.7M in cash and equivalents.
- Can Ocular Therapeutix cover its short-term obligations?
- Its current ratio is 14.81 — current assets exceed current liabilities.
- Where does Ocular Therapeutix's balance sheet data come from?
- Every line is extracted from Ocular Therapeutix's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
